ATROPINE

 

Therapeutic Class: Antidote for anticholinesterase poisoning

Pharmacologic Class: Muscarinic cholinergic receptor blocker.

ACTIONS AND USES:  By occupying muscarinic receptors, atropine blocks the parasympathetic actions of Ach and induces symptoms of the fight-or-flight response. Most prominent are increased heart rate, bronchodilation, decreased motility in the GI tract, mydriasis, and decreased secretions from glands.  

At therapeutic doses, atropine has no effect on nicotinic receptors in ganglia or on skeletal muscle. Although atropine has been used for centuries for a variety of purposes, its use has declined in recent decades because of the development of safer and more effective medications. Atropine may be used to treat hypermotility diseases of the GI tract such as irritable bowel syndrome, to suppress secretions during surgical procedures, to increase the heart rate in patients with bradycardia, and to dilate the pupil during eye examinations. Once widely used to cause bronchodilation in patients with asthma, atropine is now rarely prescribed for this disorder. Atropine therapy is useful for the treatment of reflexive bradycardia in infants and infantile hypertrophic pyloric stenosis (IHPS).

 

ADMINISTRATION ALERTS

1.  Oral and subcutaneous doses are not interchangeable.

2. Monitor blood pressure, pulse, and respirations before administration and for at least 1 hour after subcutaneous administration.

3. Pregnancy category C.

 

ADVERSE EFFECTS:  The side effects of atropine limit its therapeutic usefulness and are predictable extensions of its autonomic actions. Expected side effects include dry mouth, constipation, urinary retention, and an increased heart rate. Initial CNS excitement may progress to delirium and even coma.

CONTRAINDICATIONS: Atropine is contraindicated in patients with glaucoma, because the drug may increase pressure within the eye. Atropine should not be administered to patients with obstructive disorders of the GI tract, paralytic ileus, bladder neck obstruction, benign prostatic hyperplasia, myasthenia gravis, cardiac insufficiency, or acute hemorrhage.

INTERACTIONS:  Drug–Drug: Drug interactions with atropine include an increased effect with antihistamines, TCAs, quinidine, and procainamide. Atropine decreases effects of levodopa.

TREATMENT OF OVERDOSE:  Overdose may cause CNS stimulation or depression. A short-acting barbiturate or diazepam (Valium) may be administered to control convulsions. Physostigmine is an antidote for atropine poisoning that quickly reverses the coma caused by large doses of atropine.

 

RELATED;

1.  ACETYLCHOLINE

2.  DIAZEPAM

3.  PHARMACOLOGY AND THERAPEUTICS

REFERENCES